Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Starting soon

Conditions studied: Hepatic Encephalopathy

In brief

This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors. In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.

Key facts

Study ID

NCT06201988

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-01-01

Expected to finish

2027-01-01

Last updated by the study team

2024-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Signed Written Informed Consent
• Aged ≥ 18 years old
• No prior treatment for hepatic encephalopathy

You may not qualify if…

• Participant is actively receiving study therapy in another
• Inability to provide written informed consent
• Women of childbearing potential without a negative pregnancy test; or women who are lactating.

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.